1. Forty-eight-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV-1. (4th October 2017) Authors: Emu, Brinda; Fessel, W Jeffery; Schrader, Shannon; Kumar, Princy N; Richmond, Gary; Win, Sandra; Weinheimer, Steven; Marsolais, Christian; Lewis, Stanley Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗